Scisparc Ltd
SPRC
View Detailed Chart
0.750USD
-0.020-2.60%
Market hours （ET）Quotes delayed by 15 min
400.95KMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.60%
5 Days
-19.35%
1 Month
-46.43%
6 Months
-86.77%
Year to Date
-44.85%
1 Year
-92.06%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Scisparc Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Scisparc Ltd Info
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Ticker SymbolSPRC
CompanyScisparc Ltd
CEOWeiss (Amitay)
Websitehttps://scisparc.com/
Related Instruments
-4.09%
-1.33%
+1.48%
+0.47%
+2.74%
-0.53%
-0.97%
+1.62%
-14.41%
-3.39%
-1.42%
+0.03%
+0.74%
+1.06%
+0.68%
-0.67%
+0.97%
0.00%
-0.17%
-1.58%Popular Symbols
271.264
+1.254 (+0.46%)
178.460
-7.150 (-3.85%)
75001.500
-2967.140 (-3.81%)
286.872
+16.642 (+6.16%)
2200.030
-119.130 (-5.14%)
415.945
-5.865 (-1.39%)
4941.210
+289.490 (+6.22%)
63.219
+1.219 (+1.97%)
1.181
+0.002 (+0.20%)
155.702
+0.119 (+0.08%)
